Attenuated Salmonella Typhimurium Carrying TRAIL and VP3 Genes Inhibits the Growth of Gastric Cancer Cells in Vitro and in Vivo
Authors:
- 1 March 2010
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 96 (2) , 296-303
Abstract
Background: Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and apoptin (VP3) of chicken anemia virus can selectively induce apoptosis in human tumor cell lines by two different pathways. Salmonella not only delivers functional genes to mammalian cells but also possesses antitumor activity and therefore could be adopted as a novel vector for anticancer therapy. Materials and methods: TRAIL and VP3 genes were cloned into a pBudCE4.1 vector and delivered by attenuated Salmonella typhimurium into gastric cancer cells, and their expression and antitumor effects in nude mice were monitored by Western blot, fluorescence microscopy, MTT assay, TUNEL staining, and immunohistochemistry. Results: pBud-VP3 and pBud-TRAIL-VP3 plasmids were constructed to express TRAIL and apoptin in gastric cancer cells, leading to inhibition of cancer cell proliferation after 48 hours (P <0.05). TRAIL and VP3 genes in pBudCE4.1 vector were also successfully delivered by attenuated S. typhimurium into gastric cancer cells in vivo, in which both TRAIL and apoptin were expressed. In vivo data indicated that S. typhimurium carring pBud-TRAIL-VP3 induced significant cell growth inhibition and tumor regression (P <0.05). Moreover, expression of TRAIL and apoptin increased the expression of caspase-3 and caspase-9, resulting in enhanced apoptosis. Conclusion: Delivery of TRAIL and VP3 genes by attenuated S. typhimurium can significantly inhibit the growth of gastric cancer cells in vitro and in vivo.Keywords
This publication has 24 references indexed in Scilit:
- AttenuatedSalmonellaengineered to produce human cytokine LIGHT inhibit tumor growthProceedings of the National Academy of Sciences, 2007
- Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancerProceedings of the National Academy of Sciences, 2007
- Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanomaThe Journal of Gene Medicine, 2007
- Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathwayJournal of Cell Science, 2005
- DNA vaccines suppress tumor growth and metastases by the induction of anti‐angiogenesisImmunological Reviews, 2004
- Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to apo2l/trail‐induced apoptosisInternational Journal of Cancer, 2002
- Modulation of Tumor Necrosis Factor Apoptosis-inducing Ligand- induced NF-κB Activation by Inhibition of Apical CaspasesJournal of Biological Chemistry, 2001
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Differential sensitivity to Ad5 E1B-21kD and Bcl-2 proteins of apoptin-induced versus p53-induced apoptosisCarcinogenesis, 1995